Kwality Pharmaceuticals Ltd.

373.00 +2.05 ▲0.6%

08 December 2023, 04:01:00 PM
Volume: 7,395

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kwalitypharma.com
Market Cap 387.40 Cr.
Enterprise Value(EV) 471.66 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 10.97 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 34.04 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 203.60 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.83 Calculated using Price: 373.35
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.04 Cr. 10,376,198 Shares
FaceValue 10
About Kwality Pharmaceuticals Ltd.
The company ‘Kwality Pharmaceuticals Limited' was incorporated on May 04, 1983 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, H.P. and Chandigarh. It is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. It carries out its production through state-of-the-art manufacturing units situated at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar - 143006, Punjab, which is also its registered/administrative office and another manufacturing facility situated at 1-A Industrial Area, Raja ka bagh, Jassur, Himachal Pradesh. Both of its manufacturing facilities are well equipped and multiple products are manufactured at these facilities. Since incorporation, the company is ever progressing in Domestic and International market based on its commitment towards high quality and timely supplies. It provides specified and quality products for its customers while maintaining honesty, integrity and loyalty to its employees and customers.

Kwality Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Kwality Pharmaceuticals Ltd. Performance

1 Day
+0.55%
1 Week
-3.52%
1 Month
+9.48%
3 Month
-5.23%
6 Month
+24.52%
1 Year
+12.94%
2 Year
-62.63%
5 Year
+555.54%
10 Year

Kwality Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.43 6.54 14.41 16.51 23.13 20.10 28.21 99.66 10.15
Return on Capital Employed (%) 9.58 12.34 19.64 19.19 21.91 18.49 26.36 95.32 12.06
Return on Assets (%) 2.21 2.90 5.37 5.29 7.50 6.90 9.97 47.33 5.55

Kwality Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 19 22 26 30 37 46 61 181 201 212
Non Curr. Liab. 1 3 4 5 8 20 28 21 29 25
Curr. Liab. 17 27 42 62 61 68 78 139 126 119
Minority Int. 0 0 -1 -1 -1 -1 -1 -1 -1 -1
Equity & Liab. 37 51 71 96 105 132 166 341 354 355
Non Curr. Assets 13 13 18 21 30 43 60 113 146 150
Curr. Assets 24 38 53 75 75 89 106 228 207 205
Misc. Exp. not W/O 0 0 0 0
Total Assets 37 51 71 96 105 132 166 341 354 355

Kwality Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 52 74 98 137 166 139 262 456 251 262
Other Income 0 0 1 1 1 4 2 4 3 2
Total Income 53 75 100 138 167 143 264 460 254 265
Total Expenditure -49 -69 -89 -126 -151 -125 -233 -285 -190 -207
PBIDT 4 5 10 12 16 18 30 175 64 58
Interest -1 -1 -2 -2 -2 -3 -3 -3 -7 -8
Depreciation -1 -2 -3 -3 -3 -4 -6 -11 -15 -18
Taxation -1 -1 -2 -3 -3 -3 -6 -42 -6 -4
Exceptional Items -17 -17
PAT 1 1 3 4 8 8 15 120 19 11
Minority Interest 0 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 1 2 3 5 8 8 15 120 19 11
Adjusted EPS 1 2 3 4 7 8 15 116 19 11

Kwality Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 1 -3 4 -1 14 6 27 61 41
Cash Fr. Inv. -3 -1 -2 -7 -6 -12 -18 -23 -63 -48
Cash Fr. Finan. 3 1 6 5 5 -2 12 1 6 1
Net Change -1 1 0 2 -1 0 0 4 3 -6
Cash & Cash Eqvt 1 1 1 3 2 1 2 6 9 3

Kwality Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 54.24 54.24 54.43 54.45 54.45 54.45 54.74 54.74 54.77
Public 45.76 45.76 45.57 45.55 45.55 45.55 45.26 45.26 45.23
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kwality Pharmaceuticals Ltd. Announcements

Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
NEWSPAPER PUBLICATIONS OF FINANCIAL RESULTS FOR Q.E. 30-09-2023
Sat, 04 Nov 2023
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations') For The Half Year Ended September 30 2023
Related Party Transactions for the half year ended 30-09-2023
Sat, 04 Nov 2023
Board Meeting Outcome for Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2023
Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations) this is to inform your that Board of Directors in its meeting held today i.e. November 04 2023 have inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30 2023 along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

Kwality Pharmaceuticals Ltd. Technical Scans

Fri, 08 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Decrease in 2 Years High Decrease in 2 Years

Kwality Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Kwality Pharmaceuticals Ltd. FAQ's

What is Kwality Pharma share price?

Can I buy Kwality Pharma shares now?

What is the Market Cap of Kwality Pharma?

What are the key metrics to analyse Kwality Pharma?

What is the 52 Week High and Low of Kwality Pharma?

What is the trend of Kwality Pharma share price?